As physicians and families know too well, though Alzheimer’s disease has been intensely studied for decades, too much is still not known about molecular processes in the brain that cause it. Now researchers say new insights from analytic theory and molecular simulation techniques offer a better understanding of amyloid fibril growth and brain pathology.